SEARCH

SEARCH BY CITATION

References

  • 1
    Goodman HO, Brommage R, Assimos DG & Holmes RP. Genes in idiopathic calcium oxalate stone disease. World J Urol 1997; 15: 168171
  • 2
    Danpure CJ. Genetic disorders and urolithiasis. Urol Clin N Am 2000; 27: 28799
  • 3
    Coe FL, Parks JH & Asplin JR. The pathogenesis and treatment of kidney stones. New Eng J Med 1992; 327: 114152
  • 4
    Lorder N. Genetic variations can point the way to disease genes. Nature 1999; 401: 734DOI: 10.1038/44432
  • 5
    Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR & Jarrett TW. Familial calcium stone disease. Taq I polymorphism and the vitamin D receptor. J Endourol 1999; 13: 3136
  • 6
    Morrison NA, Qi JC & Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 2847
  • 7
    Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R & Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996; 11: 18505
  • 8
    Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B & Feldman D. The vitamin D receptor start codon polymorphism (Fok I) and bone mineral density in premenopausal American Black and White women. J Bone Miner Res 1997; 12: 10438
  • 9
    Ruggiero M, Pacini S, Amato M, Aterini S & Chiarugi V. Association between vitamin D receptor gene polymorphism and nephrolithiasis. Miner Electrolyte Metab 1999; 25: 18590
  • 10
    Zerwekh JE, Hughes MR & Reed BY et al. Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria. J Clin Endocrinol Metab 1995; 80: 29605
  • 11
    Celeste AJ, Rosen V, Buecker JL, Kriz R, Wang EA & Wozney JM. Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J 1986; 5: 188590
  • 12
    Yausi T, Fujita K & Sasaki S et al. Expression of bone matrix proteins in urolithiasis model rats. Urol Res 1999; 27: 25561DOI: 10.1007/s002400050119
  • 13
    Krishnan AV & Feldman D. Activation of protein kinase C inhibits vitamin D receptor gene expression. Mol Endocrinol 1991; 5: 60512
  • 14
    Scheinman SJ, Cox TP & Lloyd SE et al. Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria. Kid Int 2000; 57: 2329DOI: 10.1046/j.1523-1755.2000.00774.x
  • 15
    Petrucci M, Scott P & Ouimet D et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int 2000; 58: 3842DOI: 10.1046/j.1523-1755.2000.00138.x
  • 16
    Reed BY, Heller HJ, Gitomer WL & Pak CYC. Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-Q24. J Clin Endocrinol Metab 1999; 84: 390713
  • 17
    Coe FL, Parks JH & Favus MJ. Diet and calcium; the end of an era? Ann Int Med 1997; 126: 5535
  • 18
    Curhan GC, Willett WC, Rimm EB & Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Eng J Med 1993; 328: 8338
  • 19
    Pak CYC, Britton F & Peterson R et al. Ambulatory evaluation of nephrolithiasis: classification, clinical presentation, and diagnostic criteria. Am J Med 1980; 69: 1930
  • 20
    Kwok PY & Gu Z. Single nucleotide polymorphism libraries: why and how are we building them? Mol Med Today 1999; 5: 53843DOI: 10.1016/s1357-4310(99)01601-9